DGRADX Trademark

Trademark Overview


On Monday, March 14, 2022, a trademark application was filed for DGRADX with the United States Patent and Trademark Office. The USPTO has given the DGRADX trademark a serial number of 97312042. The federal status of this trademark filing is REGISTERED as of Tuesday, January 21, 2025. This trademark is owned by Booster Therapeutics GmbH. The DGRADX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Application service provider, namely, hosting online non-downloadable computer software platforms for medical research in the field of drug discovery and drug development; Programming of a drug discovery and development computer software platform for others; Online electronic data storage; Consultancy and assistance services in the nature of website design consultancy and computer software consulting, via an online website and data network platform, in the field of medical sciences; Web site hosting services of an online platform for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research, namely in the medical field of cell metabolism, ageing and cell health
dgradx

General Information


Serial Number97312042
Word MarkDGRADX
Filing DateMonday, March 14, 2022
Status700 - REGISTERED
Status DateTuesday, January 21, 2025
Registration Number7656980
Registration DateTuesday, January 21, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesApplication service provider, namely, hosting online non-downloadable computer software platforms for medical research in the field of drug discovery and drug development; Programming of a drug discovery and development computer software platform for others; Online electronic data storage; Consultancy and assistance services in the nature of website design consultancy and computer software consulting, via an online website and data network platform, in the field of medical sciences; Web site hosting services of an online platform for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research, namely in the medical field of cell metabolism, ageing and cell health

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 18, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBooster Therapeutics GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBerlin D-10629
DE

Party NameBooster Therapeutics GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBerlin D-10629
DE

Party NameBooster Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBerlin D-10629
DE

Trademark Events


Event DateEvent Description
Friday, March 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 23, 2022ASSIGNED TO EXAMINER
Thursday, March 17, 2022NEW APPLICATION ENTERED
Friday, December 30, 2022NON-FINAL ACTION E-MAILED
Friday, December 30, 2022NON-FINAL ACTION WRITTEN
Friday, December 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, July 19, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 14, 2023SUSPENSION LETTER WRITTEN
Friday, April 14, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 14, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2024ASSIGNED TO LIE
Thursday, October 24, 2024ASSIGNED TO LIE
Tuesday, November 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 5, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 5, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, November 5, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 21, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 5, 2024EXAMINERS AMENDMENT E-MAILED